News Biomaterials & Biomolecular Systems

  • Zellcluster und fluoreszierende (rot) Nanoschalter. (Bild: Benjamin Kick, Klaus Wagenbauer, Jonas Funke / TUM)

    Schaltbare Antikörper sollen Nebenwirkungen bei modernen Krebstherapien reduzieren

    Medikamente mit DNA einschalten

    20. Juli 2020 | Im Rahmen des Projekts LOGIBODY entwickeln TUM-Forschende Nanoschalter aus DNA, welche Nebenwirkungen von Krebstherapien reduzieren sollen. 

  • Logo des Virofigt-Konsortiums. Es zeigt ein stilisiertes Virus, das in einer sechseckigen Hülle eingeschlossen ist. Darunter die Aufschrift "Novel nano-technology to contain viruses"

    Europäisches Forschungskonsortium VIROFIGHT will neuartige Therapie gegen Viren vorantreiben.

    Nano-Hüllen sollen Viren einschließen und neutralisieren

    13. Juli 2020 | Europäisches Forschungskonsortium VIROFIGHT will neuartige Therapie gegen unterschiedliche Viren vorantreiben. Mit dem neuen Ansatz könnten zum Beispiel SARS-CoV-2, HIV, Hepatitis- und Influenza-Viren bekämpft werden.

  • The lubrication technology for the implant will be based on the interaction between different kinds of polymer molecules. While molecules of one kind will be attached to the inner surface of the implant, others will be dispersed in the fluid. Image: Maria Bauer / TUM

    EU supports development of novel implantation techniques for finger joints affected by osteoarthritis

    Restoring Mobility to Finger Joints

    03 Jan 2020 | Seven partners collaborating in the European research project APRICOT aim to develop a radically new type of implant for the treatment of osteoarthritis of small joints in the hand.

  • EU flag and ERC logo

    ERC consolidator grant awarded to MSB-PI Gil Westmeyer

    Visualizing neuronal information processing

    11 Dec 2019 | ERC consolidator grant awarded to MSB-PI Gil Westmeyer for a project on the direct visualization of molecular states of neurons.

  • The Logibody team at the award ceremony.

    Research team mentored by MSB-PI Hendrik Dietz receives m4 Award

    Developing a nanoswitch for antibodies

    25 Oct 2019 | A research team mentored by MSB-PI Hendrik Dietz has received a m4 Award. They have developed a nanoswitch made from DNA that will allow immunotherapies against cancer to target tumors more specifically.

  • Two kinds of nanocompartments with different sizes that contain metal particles and thus can be easily distinguished in an Electron Microscopy.  Image: B. van Rossum / FMP

    Shape is the new color

    08 August 2019 | Self-assembling nanoparticles mark cells in electron microscopy.

  • Prof. Oliver Lieleg and PhD student Ceren Kimna use balls and pipe cleaners in different colors to visualize how nanoparticles can be bound together by DNA fragments. Such connections may become the basis of drugs that release their active ingredients in sequence. Image: Uli Benz / TUM

    Artificial DNA can control release of active ingredients from drugs

    01 July 2019 | A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.